Home Stock

Stock Research: Teva Pharmaceutical Industries

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Teva Pharmaceutical Industries

TLV:TEVA US8816242098
25
  • Value
    36
  • Growth
    59
  • Safety
    Safety
    1
  • Combined
    11
  • Sentiment
    96
  • 360° View
    360° View
    25
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Teva Pharmaceutical Industries Ltd. is an Israeli-based pharmaceutical company that manages a full product portfolio including generics, specialty, and over-the-counter (OTC) products, and also engages in selling active pharmaceutical ingredients (API) to third parties and contract manufacturing services. The company operates in North America, Europe, and International Markets. In the last fiscal year, the company had a market cap of $18517 million, profits of $8292 million, revenue of $16544 million, and 33892 employees.

more
Strongest Rank Safety
Weakest Rank Sentiment
Country Israel
Industry Pharmaceuticals
Size Large
Website tevapharm.com
Index
Teva Pharmaceutical Industries stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 27-Feb-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
36 60 77 78
Growth
59 40 31 15
Safety
Safety
1 12 6 4
Sentiment
96 37 36 6
360° View
360° View
25 28 12 10
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
65 72 26 17
Opinions Change
50 6 74 50
Pro Holdings
n/a 23 37 46
Market Pulse
87 67 49 17
Sentiment
96 37 36 6
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
36 60 77 78
Growth
59 40 31 15
Safety Safety
1 12 6 4
Combined
11 17 16 12
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
62 59 87 97
Price vs. Earnings (P/E)
44 91 97 97
Price vs. Book (P/B)
38 45 71 92
Dividend Yield
1 1 1 1
Value
36 60 77 78
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
24 21 8 16
Profit Growth
36 32 37 32
Capital Growth
52 51 49 51
Stock Returns
96 80 72 24
Growth
59 40 31 15
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
7 3 4 5
Refinancing
11 13 13 22
Liquidity
37 51 32 23
Safety Safety
1 12 6 4

Similar Stocks

Discover high‑ranked alternatives to Teva Pharmaceutical Industries and broaden your portfolio horizons.

STMicroelectronics

PAR:STMPA
Country: Netherlands
Industry: Semiconductors
Size: X-Large
Full Stock Analysis

Ternium

NYQ:TX
Country: Netherlands
Industry: Steel
Size: X-Large
Full Stock Analysis

Grifols

MCE:GRF
Country: Spain
Industry: Biotechnology
Size: X-Large
Full Stock Analysis

Richter Gedeon

BUD:RICHTER
Country: Hungary
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Frequently Asked
Questions

Only the professional market sentiment is positive. The stock is expensive, has low growth, and low financial safety. This is a weak investment proposition. Only a small, highly-speculative investment may be justified by investors who strongly believe the positive sentiment points to an positive future.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews